Harm Reduction at its Best: A case for Promoting Safe Injection Facilities
Barre latérale de l'article
Publié-e :
nov. 17, 2014
Mots-clés :
Safe Injection Facilities, Harm Reduction
Contenu principal de l'article
Résumé
Injection Drug Users (IDU) represent less than 1% of Canada's the total population. Nevertheless, it is estimated that health and law enforcement costs for controlling the drug problem in Canada amount to $5 billion annually. The current strategies targeting IDU have limited efficacy with reducing emergency department visits, limiting HIV/Hep C virus transmission and providing accessible health care. This paper makes the case for safe injection facilities (SIF) as a means to improve IDU health outcomes, while reducing health care expenditures, decreasing public injecting and having no impact on crime rates. This topic is of particular concern now that the Conservative government is in the process of trying to pass bill C-2 to modify the Controlled Drugs and Substance Act making exemptions for SIF inaccessible. This is occurring while leading researchers in the field are applying for an exemption for such a facility in Ottawa.
Renseignements sur l'article
Rubrique
Commentary
- Les auteurs qui publient dans le JMUO gardent les droits d’auteur de leurs articles, incluant tous les brouillons et la copie finale publiée dans le journal
- Bien que le JMUO n’a pas les droits d’auteur des articles soumis, en acceptant de publier dans le JMUO, les auteurs donnent le droit au journal d’être les premiers à publier et à distribuer leurs articles.
- Par la suite, les auteurs peuvent soumettre leurs documents à d’autres publications, incluant des revues ou des livres, avec un remerciement de leur première publication dans le JMUO
- Des copies du JMUO seront distribuées à la fois sous format papier et en ligne, et tous les matériaux seront accessibles au public en ligne. Le journal n’a pas de responsabilité légale par rapport à la distribution publique du contenu.
- Prière de vous assurer que tous les auteurs, les coauteurs et les investigateurs
- Le contenu est rendu disponible sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Références
Anderson, M, A. & Boyd, N. (2010). A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. International Journal of Drug Policy, 21(1), 70-76. doi: 10.1016/j.drugpo.2009.03.004.
Begin, P., Weekes, J. & Thomas, G. (2004). The Canadian addiction survey : Substance use and misuse among the Canadian population. Canadian Center on Substance Abuse. Retrieved from: http://www.csc-scc.gc.ca/publications/forum/e181/e181d_e.pdf
CBC News. (2013, August 31). Overdoses in Ottawa a preventable problem, say activists (2013). CBC news. Retrieved from: http://www.cbc.ca/news/canada/ottawa/overdoses-in-ottawa-a-preventable-problem-say-activists-1.1408951
Chitwood, D, D., McBride, D, C., French, M, T. & Comeford, M. (1999). Healthcare need utilization: A preliminary comparison of injection drug users, other illicit drug users and nonusers. Substance use & misuse. 35(4&5), 727-746. Retrieved from http://informahealthcare.com/loi/sum
Hilton B, A., Thompson, R., Moore-Dempsey, L. & Janzen, R, G. (2000). Harm reduction theories and strategies for control of immunodeficiency virus: A review of the literature. Journal of advanced nursing, 33(3), 357-370. doi:10.1046/j.1365-2648.2001.01672.x
MacAdam, M. (2008). Sustainability of Canada's health care system. Health Policy Monitor. Retrieved from http://www.hpm.org/survey/ca/b12/1
Marshall, B, D, L., Milloy, M-J., Wood, E., Montaner, J, S, G. & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet, 377(9775), 1429-1437. doi: 10.1016/S0140-6736(10)62353-7.
National Institute on Drug Abuse. (1995). Methadone maintenance treatment: Translating research into policy. NISA Reseach Monograph Washington DC. National Institutes of Health, U.S. Public Health Services Retreived from: http://chodarr.org/sites/default/files/chodarr1448.pdf
Office of the Auditor General of Canada. (2001).2001 December report of the auditor general of Canada, Chapter 11—Illicit drugs: The federal government’s role. Retrieved from : http://www.oag-bvg.gc.ca/internet/English/parl_oag_200112_11_e_11832.html
Palepu, A., Tyndall, M, W., Leon, H., Muller, J., O'Shaughnessy, M, V., Schechter, M, T. & Anis, A, H. (2001). Hospital utilization and costs in cohort of injection drug users. Canadian Medical Association Journal, 165(4), 415-420. Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC81365/
Pinkerton, S, D. (2010). Is Vancouver Canada's supervised injection facility cost-saving? Addiction, 105(8), 1429-1436. doi:10.1111/j.1360-0443.2010.02977.x
Wood, E., Kerr, T., Spittal, P, M., Tyndall, M, W., O’Shaughnessy, M, V. & Schechter, M, T. (2003). The health care and fiscal costs of the illicit drug use epidemic: The impact of conventional drug control strategies, and the potential of a comprehensive approach. BC Medical Journal, 45(3), 128-134. Retrieved from: http://www.bcmj.org/
Wood, E., Tyndall, M, W., Montaner, J, S., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised injecting facility. Canadian Medical Association Journal, 175 (11), 1399-1404. doi: 10.1503/cmaj.060863
Begin, P., Weekes, J. & Thomas, G. (2004). The Canadian addiction survey : Substance use and misuse among the Canadian population. Canadian Center on Substance Abuse. Retrieved from: http://www.csc-scc.gc.ca/publications/forum/e181/e181d_e.pdf
CBC News. (2013, August 31). Overdoses in Ottawa a preventable problem, say activists (2013). CBC news. Retrieved from: http://www.cbc.ca/news/canada/ottawa/overdoses-in-ottawa-a-preventable-problem-say-activists-1.1408951
Chitwood, D, D., McBride, D, C., French, M, T. & Comeford, M. (1999). Healthcare need utilization: A preliminary comparison of injection drug users, other illicit drug users and nonusers. Substance use & misuse. 35(4&5), 727-746. Retrieved from http://informahealthcare.com/loi/sum
Hilton B, A., Thompson, R., Moore-Dempsey, L. & Janzen, R, G. (2000). Harm reduction theories and strategies for control of immunodeficiency virus: A review of the literature. Journal of advanced nursing, 33(3), 357-370. doi:10.1046/j.1365-2648.2001.01672.x
MacAdam, M. (2008). Sustainability of Canada's health care system. Health Policy Monitor. Retrieved from http://www.hpm.org/survey/ca/b12/1
Marshall, B, D, L., Milloy, M-J., Wood, E., Montaner, J, S, G. & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: A retrospective population-based study. The Lancet, 377(9775), 1429-1437. doi: 10.1016/S0140-6736(10)62353-7.
National Institute on Drug Abuse. (1995). Methadone maintenance treatment: Translating research into policy. NISA Reseach Monograph Washington DC. National Institutes of Health, U.S. Public Health Services Retreived from: http://chodarr.org/sites/default/files/chodarr1448.pdf
Office of the Auditor General of Canada. (2001).2001 December report of the auditor general of Canada, Chapter 11—Illicit drugs: The federal government’s role. Retrieved from : http://www.oag-bvg.gc.ca/internet/English/parl_oag_200112_11_e_11832.html
Palepu, A., Tyndall, M, W., Leon, H., Muller, J., O'Shaughnessy, M, V., Schechter, M, T. & Anis, A, H. (2001). Hospital utilization and costs in cohort of injection drug users. Canadian Medical Association Journal, 165(4), 415-420. Retrieved from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC81365/
Pinkerton, S, D. (2010). Is Vancouver Canada's supervised injection facility cost-saving? Addiction, 105(8), 1429-1436. doi:10.1111/j.1360-0443.2010.02977.x
Wood, E., Kerr, T., Spittal, P, M., Tyndall, M, W., O’Shaughnessy, M, V. & Schechter, M, T. (2003). The health care and fiscal costs of the illicit drug use epidemic: The impact of conventional drug control strategies, and the potential of a comprehensive approach. BC Medical Journal, 45(3), 128-134. Retrieved from: http://www.bcmj.org/
Wood, E., Tyndall, M, W., Montaner, J, S., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised injecting facility. Canadian Medical Association Journal, 175 (11), 1399-1404. doi: 10.1503/cmaj.060863